tetano
Editor, Senior Moderator
Life (Basel)
. 2022 Jan 4;12(1):68.
doi: 10.3390/life12010068.
Evaluation of Three Automated Extraction Systems for the Detection of SARS-CoV-2 from Clinical Respiratory Specimens
Ho-Jae Lim[SUP] 1 2 [/SUP], Hye-Soo Jung[SUP] 1 [/SUP], Min-Young Park[SUP] 1 [/SUP], Young-Hyun Baek[SUP] 1 [/SUP], Balaji Kannappan[SUP] 2 [/SUP], Jin-Young Park[SUP] 3 [/SUP], Jae-Hyun Yang[SUP] 4 [/SUP], Ja-Hwan Seol[SUP] 5 [/SUP], Min-Woo Lee[SUP] 6 [/SUP], Sun-Kyung Jung[SUP] 1 [/SUP], Sun-Hwa Lee[SUP] 1 [/SUP], Jung-Eun Park[SUP] 2 [/SUP], Yong-Jin Yang[SUP] 1 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is highly contagious and causes coronavirus disease 2019 (COVID-19). Reverse transcription quantitative polymerase chain reaction (RT-qPCR) is the most accurate and reliable molecular assay to detect active SARS-CoV-2 infection. However, a rapid increase in test subjects has created a global bottleneck in testing capacity. Given that efficient nucleic acid extraction greatly affects reliable and accurate testing results, we compared three extraction platforms: MagNA Pure 96 DNA and Viral NA Small Volume kit on MagNA Pure 96 (Roche, Basel, Switzerland), careGENE[SUP]TM[/SUP] Viral/Pathogen HiFi Nucleic Acid Isolation kit (WELLS BIO Inc., Seoul, Korea) on KingFisher Flex (Thermo Fisher Scientific, Rocklin, CA, USA), and SGRespi[SUP]TM[/SUP] Pure kit (Seegene Inc., Seoul, Korea) on Maelstrom 9600 (Taiwan Advanced Nanotech Inc., Taoyuan, Taiwan). RNA was extracted from 245 residual respiratory specimens from the different types of samples (i.e., NPS, sputum, and saliva) using three different kits. The 95% limits of detection of median tissue culture infectious dose per milliliter (TCID[SUB]50[/SUB]/mL) for the MagNA Pure 96, KingFisher Flex, and Maelstrom 9600 were 0.37-3.15 × 10[SUP]1[/SUP], 0.41-3.62 × 10[SUP]1[/SUP], and 0.33-1.98 × 10[SUP]1[/SUP], respectively. The KingFisher Flex platform exhibited 99.2% sensitivity and 100% specificity, whereas Maelstrom 9600 exhibited 98.3-100% sensitivity and 100% specificity. Bland-Altman analysis revealed a 95.2% concordance between MagNA Pure 96 and KingFisher Flex and 95.4% concordance between MagNA Pure 96 and Maelstrom 9600, indicating that all three platforms provided statistically reliable results. This suggests that two modifying platforms, KingFisher Flex and Maelstrom 9600, are accurate and scalable extraction platforms for large-scale SARS-CoV-2 clinical detection and could help the management of COVID-19 patients.
Keywords: SARS-CoV-2; automated extraction system; mRT-qPCR.
. 2022 Jan 4;12(1):68.
doi: 10.3390/life12010068.
Evaluation of Three Automated Extraction Systems for the Detection of SARS-CoV-2 from Clinical Respiratory Specimens
Ho-Jae Lim[SUP] 1 2 [/SUP], Hye-Soo Jung[SUP] 1 [/SUP], Min-Young Park[SUP] 1 [/SUP], Young-Hyun Baek[SUP] 1 [/SUP], Balaji Kannappan[SUP] 2 [/SUP], Jin-Young Park[SUP] 3 [/SUP], Jae-Hyun Yang[SUP] 4 [/SUP], Ja-Hwan Seol[SUP] 5 [/SUP], Min-Woo Lee[SUP] 6 [/SUP], Sun-Kyung Jung[SUP] 1 [/SUP], Sun-Hwa Lee[SUP] 1 [/SUP], Jung-Eun Park[SUP] 2 [/SUP], Yong-Jin Yang[SUP] 1 [/SUP]
Affiliations
- PMID: 35054463
- DOI: 10.3390/life12010068
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is highly contagious and causes coronavirus disease 2019 (COVID-19). Reverse transcription quantitative polymerase chain reaction (RT-qPCR) is the most accurate and reliable molecular assay to detect active SARS-CoV-2 infection. However, a rapid increase in test subjects has created a global bottleneck in testing capacity. Given that efficient nucleic acid extraction greatly affects reliable and accurate testing results, we compared three extraction platforms: MagNA Pure 96 DNA and Viral NA Small Volume kit on MagNA Pure 96 (Roche, Basel, Switzerland), careGENE[SUP]TM[/SUP] Viral/Pathogen HiFi Nucleic Acid Isolation kit (WELLS BIO Inc., Seoul, Korea) on KingFisher Flex (Thermo Fisher Scientific, Rocklin, CA, USA), and SGRespi[SUP]TM[/SUP] Pure kit (Seegene Inc., Seoul, Korea) on Maelstrom 9600 (Taiwan Advanced Nanotech Inc., Taoyuan, Taiwan). RNA was extracted from 245 residual respiratory specimens from the different types of samples (i.e., NPS, sputum, and saliva) using three different kits. The 95% limits of detection of median tissue culture infectious dose per milliliter (TCID[SUB]50[/SUB]/mL) for the MagNA Pure 96, KingFisher Flex, and Maelstrom 9600 were 0.37-3.15 × 10[SUP]1[/SUP], 0.41-3.62 × 10[SUP]1[/SUP], and 0.33-1.98 × 10[SUP]1[/SUP], respectively. The KingFisher Flex platform exhibited 99.2% sensitivity and 100% specificity, whereas Maelstrom 9600 exhibited 98.3-100% sensitivity and 100% specificity. Bland-Altman analysis revealed a 95.2% concordance between MagNA Pure 96 and KingFisher Flex and 95.4% concordance between MagNA Pure 96 and Maelstrom 9600, indicating that all three platforms provided statistically reliable results. This suggests that two modifying platforms, KingFisher Flex and Maelstrom 9600, are accurate and scalable extraction platforms for large-scale SARS-CoV-2 clinical detection and could help the management of COVID-19 patients.
Keywords: SARS-CoV-2; automated extraction system; mRT-qPCR.